Tenet Healthcare Shareholders’ Equity Growth & History (THC)
Tenet Healthcare's shareholders’ equity was $4.22B for fiscal 2025.
View full Tenet Healthcare company overviewTenet Healthcare annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.22B | $49.0M | +1.17% |
| 2024 | 2024-12-31 | $4.17B | $2.56B | +159.39% |
| 2023 | 2023-12-31 | $1.61B | $466.0M | +40.81% |
| 2022 | 2022-12-31 | $1.14B | $114.0M | +11.09% |
| 2021 | 2021-12-31 | $1.03B | $1.00B | +3571.43% |
| 2020 | 2020-12-31 | $28.0M | $445.0M | — |
| 2019 | 2019-12-31 | −$417.0M | −$298.0M | — |
| 2018 | 2018-12-31 | −$119.0M | $28.0M | — |
| 2017 | 2017-12-31 | −$147.0M | −$564.0M | — |
| 2016 | 2016-12-31 | $417.0M | −$274.0M | −39.65% |
| 2015 | 2015-12-31 | $691.0M | $40.0M | +6.14% |
| 2014 | 2014-12-31 | $651.0M | −$104.0M | −13.77% |
| 2013 | 2013-12-31 | $755.0M | −$388.0M | −33.95% |
| 2012 | 2012-12-31 | $1.14B | −$280.0M | −19.68% |
| 2011 | 2011-12-31 | $1.42B | −$343.0M | −19.42% |
| 2010 | 2010-12-31 | $1.77B | $1.12B | +173.37% |
| 2009 | 2009-12-31 | $646.0M | $499.0M | +339.46% |
| 2008 | 2008-12-31 | $147.0M | — | — |
Tenet Healthcare quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.66B | $909.0M | +24.25% |
| Q1 2026 | 2026-03-31 | $4.81B | $633.0M | +15.14% |
| Q4 2025 | 2025-12-31 | $4.22B | $49.0M | +1.17% |
| Q3 2025 | 2025-09-30 | $4.01B | $180.0M | +4.69% |
| Q2 2025 | 2025-06-30 | $3.75B | $274.0M | +7.88% |
| Q1 2025 | 2025-03-31 | $4.18B | $728.0M | +21.08% |
| Q4 2024 | 2024-12-31 | $4.17B | $2.56B | +159.39% |
| Q3 2024 | 2024-09-30 | $3.83B | $2.37B | +161.89% |
| Q2 2024 | 2024-06-30 | $3.48B | $2.13B | +158.75% |
| Q1 2024 | 2024-03-31 | $3.45B | $2.22B | +180.05% |
| Q4 2023 | 2023-12-31 | $1.61B | $466.0M | +40.81% |
| Q3 2023 | 2023-09-30 | $1.46B | $229.0M | +18.54% |
| Q2 2023 | 2023-06-30 | $1.34B | $256.0M | +23.55% |
| Q1 2023 | 2023-03-31 | $1.23B | $177.0M | +16.76% |
| Q4 2022 | 2022-12-31 | $1.14B | $114.0M | +11.09% |
| Q3 2022 | 2022-09-30 | $1.24B | $513.0M | +71.05% |
| Q2 2022 | 2022-06-30 | $1.09B | $826.0M | +316.48% |
| Q1 2022 | 2022-03-31 | $1.06B | $933.0M | +758.54% |
| Q4 2021 | 2021-12-31 | $1.03B | $1.00B | +3571.43% |
| Q3 2021 | 2021-09-30 | $722.0M | $1.10B | — |
| Q2 2021 | 2021-06-30 | $261.0M | $518.0M | — |
| Q1 2021 | 2021-03-31 | $123.0M | $481.0M | — |
| Q4 2020 | 2020-12-31 | $28.0M | $445.0M | — |
| Q3 2020 | 2020-09-30 | −$374.0M | −$33.0M | — |
| Q2 2020 | 2020-06-30 | −$257.0M | −$149.0M | — |
| Q1 2020 | 2020-03-31 | −$358.0M | −$224.0M | — |
| Q4 2019 | 2019-12-31 | −$417.0M | −$298.0M | — |
| Q3 2019 | 2019-09-30 | −$341.0M | −$233.0M | — |
| Q2 2019 | 2019-06-30 | −$108.0M | $46.0M | — |
| Q1 2019 | 2019-03-31 | −$134.0M | −$69.0M | — |
| Q4 2018 | 2018-12-31 | −$119.0M | $28.0M | — |
| Q3 2018 | 2018-09-30 | −$108.0M | −$132.0M | — |
| Q2 2018 | 2018-06-30 | −$154.0M | −$527.0M | — |
| Q1 2018 | 2018-03-31 | −$65.0M | −$495.0M | — |
| Q4 2017 | 2017-12-31 | −$147.0M | −$564.0M | — |
| Q3 2017 | 2017-09-30 | $24.0M | −$504.0M | −95.45% |
| Q2 2017 | 2017-06-30 | $373.0M | −$150.0M | −28.68% |
| Q1 2017 | 2017-03-31 | $430.0M | −$195.0M | −31.20% |
| Q4 2016 | 2016-12-31 | $417.0M | −$274.0M | −39.65% |
| Q3 2016 | 2016-09-30 | $528.0M | −$274.0M | −34.16% |
| Q2 2016 | 2016-06-30 | $523.0M | −$280.0M | −34.87% |
| Q1 2016 | 2016-03-31 | $625.0M | −$214.0M | −25.51% |
| Q4 2015 | 2015-12-31 | $691.0M | $40.0M | +6.14% |
| Q3 2015 | 2015-09-30 | $802.0M | $67.0M | +9.12% |
| Q2 2015 | 2015-06-30 | $803.0M | $80.0M | +11.07% |
| Q1 2015 | 2015-03-31 | $839.0M | $111.0M | +15.25% |
| Q4 2014 | 2014-12-31 | $651.0M | −$104.0M | −13.77% |
| Q3 2014 | 2014-09-30 | $735.0M | −$90.0M | −10.91% |
| Q2 2014 | 2014-06-30 | $723.0M | −$172.0M | −19.22% |
| Q1 2014 | 2014-03-31 | $728.0M | −$241.0M | −24.87% |
| Q4 2013 | 2013-12-31 | $755.0M | −$388.0M | −33.95% |
| Q3 2013 | 2013-09-30 | $825.0M | −$399.0M | −32.60% |
| Q2 2013 | 2013-06-30 | $895.0M | −$281.0M | −23.89% |
| Q1 2013 | 2013-03-31 | $969.0M | −$491.0M | −33.63% |
| Q4 2012 | 2012-12-31 | $1.14B | −$280.0M | −19.68% |
| Q3 2012 | 2012-09-30 | $1.22B | −$474.0M | −27.92% |
| Q2 2012 | 2012-06-30 | $1.18B | −$634.0M | −35.03% |
| Q1 2012 | 2012-03-31 | $1.46B | −$384.0M | −20.82% |
| Q4 2011 | 2011-12-31 | $1.42B | −$343.0M | −19.42% |
| Q3 2011 | 2011-09-30 | $1.70B | −$13.0M | −0.76% |
| Q2 2011 | 2011-06-30 | $1.81B | $1.04B | +134.46% |
| Q1 2011 | 2011-03-31 | $1.84B | — | — |
| Q4 2010 | 2010-12-31 | $1.77B | $1.12B | +173.37% |
| Q3 2010 | 2010-09-30 | $1.71B | — | — |
| Q2 2010 | 2010-06-30 | $772.0M | — | — |
| Q4 2009 | 2009-12-31 | $646.0M | — | — |
Tenet Healthcare shareholders’ equity trends
Over the last five fiscal years, Tenet Healthcare's shareholders’ equity increased from $28.0M to $4.22B, a change of $4.19B. The latest reported quarter, Q2 2026, shows $4.66B.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenet Healthcare source filings ↗